Covid-19 Vaccine Provider Guidance

ODH Information

  • Interim Considerations: Preparing for the Potential Management of Anaphylaxis After COVID-19 Vaccination

    • Anaphylaxis, an acute and potentially life-threatening allergic reaction, has been reported following COVID-19 vaccination. Detailed information on CDC recommendations for vaccination, including contraindications and precautions to vaccination are listed on this page.
  • Vaccine Provider Resources

    • ODH complied these resources for Ohio providers interested in participating in the COVID-19 Vaccination Program information regarding vaccine training, storage, handling and reporting and other COVID-19 vaccine specific information.  Contains links to manufacture specifications, temperature monitoring, provider enrollment, vaccine planning assumptions.
  • Vaccine Provider Training

    • Providers enrolled in the COVID-19 Vaccination Program are required to review and be familiar with the training documents and resources listed below.  These documents contain information regarding general immunization guidelines, storage and handling, and temperature monitoring practices. 
  • Vaccine Fact Sheets: Moderna & Pfizer

  • CDC's Vaccine Adverse Reporting System (VEARS) or call 1 (800) 822-7967

  • Vaccine Provider Communication Tool Kit

    •  ODH Communication Toolkit with talking points, language tips, graphics, FAQs, myths vs. facts, social media language, and trusted resources to help you better communicate about the COVID-19 vaccination with your stakeholders.

Phase 1 LHD Vaccine Prioritization

Centers for Disease Control and Prevention Vaccine